San Francisco, CA, United States of America

Kurt Deshayes

This inventor holds 7 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Genentech, Inc., Abbott Laboratories Corporation, Walter and Eliza Hall Institute of Medical Research. Active years: 2006-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kurt Deshayes. Retrieved from https://idiyas.com/inventor/kurt-deshayes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 85.7

 

 

Average Co-Inventor Count = 6.3

ph-index = 4

Forward Citations = 142(Granted Patents)


Company Filing History:


Years Active: 2006-2015

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor Kurt Deshayes: Pioneering Innovations in San Francisco

Introduction: Kurt Deshayes is a visionary inventor based in San Francisco, CA, known for his groundbreaking contributions to various technological fields.

Latest Patents: Kurt Deshayes holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Kurt Deshayes has worked with leading research institutions and tech companies, consistently pushing the boundaries of innovation.

Collaborations: Throughout his career, Kurt Deshayes has collaborated with top engineers, scientists, and designers, fostering a culture of creativity and excellence in all his projects.

Conclusion: Kurt Deshayes continues to inspire the next generation of inventors with his passion for innovation and his relentless pursuit of technological advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…